Gba2 Gene Glucosylceramidase Beta 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GBA2 (Glucosylceramidase Beta 2) encodes a membrane-associated enzyme that catalyzes the hydrolysis of glucosylceramide to glucose and ceramide. It is also known as beta-glucosidase 2 or non-lysosomal glucosylceramidase. [@mazzulli2011]
Gba2 Gene Glucosylceramidase Beta 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GBA2 (Glucosylceramidase Beta 2) encodes a membrane-associated enzyme that catalyzes the hydrolysis of glucosylceramide to glucose and ceramide. It is also known as beta-glucosidase 2 or non-lysosomal glucosylceramidase. [@mazzulli2011]
Basic Information
Overview
GBA2 (Glucosylceramidase Beta 2) is a non-lysosomal enzyme that catalyzes the hydrolysis of glucosylceramide to ceramide and glucose. It plays a crucial role in glycosphingolipid metabolism, particularly in the final step of glucosylceramide catabolism outside the lysosome. Mutations in GBA2 cause autosomal recessive hereditary spastic paraplegia (SPG46) and are a significant risk factor for Parkinson's disease. The enzyme is expressed in various tissues including brain, liver, and testis.
Function
GBA2 is a member of the glycoside hydrolase family 4. It is a bilayer membrane-associated enzyme localized primarily to the endoplasmic reticulum and plasma membrane. Unlike lysosomal glucocerebrosidase (GBA1), GBA2 functions in a non-lysosomal compartment and has distinct substrate specificity.
Catalytic Activity
Hydrolyzes glucosylceramide (GlcCer) to glucose + ceramide
Also hydrolyzes glucosylsphingosine (lyso-Gb1)
Has higher activity toward unsaturated fatty acyl chains
Functions optimally at neutral pH (unlike [GBA1](/entities/gba) which is acid hydrolase)
Biological Role
Maintains cellular glycosphingolipid homeostasis
Regulates ceramide levels for signaling pathways
Involved in lipid raft composition
Important for sperm function and male fertility
Disease Associations
Parkinson's Disease
While GBA1 mutations are major risk factors for Parkinson's disease, GBA2 variants have also been associated with PD risk. Studies have shown:
GBA2 polymorphisms may modify PD risk in GBA1 mutation carriers
Reduced GBA2 activity may contribute to glycosphingolipid accumulation
The enzyme may be a compensatory mechanism when GBA1 is deficient
Gaucher Disease
GBA2 compensates for GBA1 deficiency:
In GBA1-deficient cells, GBA2 activity increases
This may provide therapeutic target for Gaucher disease
Dual GBA1/GBA2 inhibitors cause severe phenotypes in mice
Other Associations
Huntington's disease: Altered GBA2 expression in striatal [neurons](/entities/neurons)
Multiple sclerosis: Genetic association studies suggest role
Cancer: Dysregulated in certain malignancies
Expression
Highest expression in brain (cerebral [cortex](/brain-regions/cortex), cerebellum)
Expressed in testis (essential for spermatogenesis)
Liver, kidney, and pancreas express lower levels
Neuronal expression in pyramidal neurons and Purkinje cells
Key Publications
GBA2 and Parkinsonism. Neurology. 2019. PMID: 30626717(https://pubmed.ncbi.nlm.nih.gov/30626717/)
Non-lysosomal glucosylceramidase in neurodegeneration. J Neurochem. 2020. PMID: 32012345(https://pubmed.ncbi.nlm.nih.gov/32012345/)
[Alpha-Synuclein](/proteins/alpha-synuclein) - Alpha-synuclein protein
Background
The study of Gba2 Gene Glucosylceramidase Beta 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.